Search

Your search keyword '"Ronner E"' showing total 217 results

Search Constraints

Start Over You searched for: Author "Ronner E" Remove constraint Author: "Ronner E"
217 results on '"Ronner E"'

Search Results

1. Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry

3. Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary Syndrome

5. Serially measured high-sensitivity cardiac troponin T, N-terminal-pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and growth differentiation factor 15 for risk assessment after acute coronary syndrome: the BIOMArCS cohort.

7. Exploring crop diversity to develop better systems for protein production

8. Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice:: GLORIA-AF Registry

10. Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry (Clinical Research in Cardiology, (2022), 111, 5, (560-573), 10.1007/s00392-022-01996-2)

11. Dapagliflozin and cardiovascular outcomes in type 2 diabetes

12. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

13. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

14. Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary Syndrome

15. Participatory exploration of transformative pathways for the cooking banana value chain in Uganda

16. Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry

17. Basket of options : Unpacking the concept

18. Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease

19. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

20. Basket of options: Unpacking the concept

22. Evolution of renal function and predictive value of serial renal assessments among patients with acute coronary syndrome: BIOMArCS study

23. Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF)

27. N2Africa Dissemination tools

29. N2Africa Annual Report 2018

30. Responses to inoculation of Phaseolus beans on N2Africa trials in Ethiopia, Tanzania, Rwanda and Zimbabwe

31. Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery

32. N2Africa Annual Report 2019

33. Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial

39. Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial

40. Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

41. Temporal Pattern of Growth Differentiation Factor-15 Protein After Acute Coronary Syndrome (From the BIOMArCS Study)

42. Evolution of renal function and predictive value of serial renal assessments among patients with acute coronary syndrome: BIOMArCS study

44. Temporal Pattern of Growth Differentiation Factor-15 Protein After Acute Coronary Syndrome (From the BIOMArCS Study)

46. Co-design of improved climbing bean production practices for smallholder farmers in the highlands of Uganda

47. The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

48. Empagliflozin and Kidney Function Decline in Patients with Type 2 Diabetes: A Slope Analysis from the EMPA-REG OUTCOME Trial

49. Farmers' use and adaptation of improved climbing bean production practices in the highlands of Uganda

50. N2Africa Annual Report 2017

Catalog

Books, media, physical & digital resources